Sort
326,823 grants matching “clinical trial”
Clinical Trial Unit for HIV Prevention and Microbicide Research
$2,097,793Kenneth H Mayer · Fenway Community Health Center · U01 · FY2009 · AI
The Louisiana Clinical Center of Nutrition for Precision Health (LA-NPH)
$2,097,765Eric Ravussin · Lsu Pennington Biomedical Research Ctr · UG1 · FY2025 · HD
CANCER RESEARCH CENTER OF HAWAII
$2,097,499University Of Hawaii At Manoa · P30 · FY2000 · CA
Molecular Transducers of Physical Activity Clinical Centers (U01) - UT Health San Antonio Clinical Center
$2,097,226Nicolas Musi · University Of Texas Hlth Science Center · U01 · FY2022 · AR
SPORE in Lung Cancer
$2,097,159Stephen B Baylin · Johns Hopkins University · P50 · FY2011 · CA
Liver Cirrhosis Network: Scientific and Data Coordination Center
$2,096,971Jody D. Ciolino · Northwestern University At Chicago · U24 · FY2022 · DK
Development of an implantable closed-loop system for delivery of naloxone for the prevention of opioid-related overdose deaths
$2,096,911Robert W Gereau · Washington University · UG3 · FY2019 · DA
Elafin Therapy for Lung Diseases
$2,096,783Marlene Rabinovitch · Stanford University · P01 · FY2014 · HL
Sex-specific mechanisms of cortical circuit dysfunction in a mouse ASD model
$2,096,266Kimberly M Huber · Ut Southwestern Medical Center · R37 · FY2020 · NS
Georgetown University Lombardi Comprehensive Cancer Center Support Grant
$2,096,005Louis M Weiner · Georgetown University · P30 · FY2025 · CA
Development of New Antitumor Agents
$2,095,999Southern Research Institute · P01 · FY2002 · CA
A Clinical Trial of Three Broadly Neutralizing Antibodies and Analytic Treatment Interruption in Early-Treated Children in Botswana
$2,095,803Roger L Shapiro · Harvard University D/B/A Harvard School Of Public Health · U01 · FY2024 · AI
Proof of concept and dose response of CAM-6019 for HFrEF patients
$2,095,748Kfir Umansky · Velakor Biotherapeutics, Inc. · R44 · FY2025 · HL
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD (UW-MADISON)(UL1)
$2,095,628Marc K. Drezner · University Of Wisconsin-Madison · UL1 · FY2011 · RR
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$2,095,587Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2021 · AI
GENE THERAPY FOR BRAIN TUMORS
$2,095,552Massachusetts General Hospital · P01 · FY2002 · CA
TECHNICAL INFORMATION RESEARCH RESOURCES FOR CANCER PREVENTIVE AGENT DEVELOPMENT
$2,095,519Caroline C Sigman · Ccs Associates, Inc. · N02 · FY2017 · CA
A Phase 2 Trial of AAV-NGF Gene Delivery in Alzheimer's Disease
$2,095,517Paul S. Aisen · University Of California, San Diego · R01 · FY2008 · AG
Functional Polymorphism Analysis in Drug Pathways
$2,095,429Washington University · U01 · FY2001 · GM
NGTC - UCL
$2,095,142Martin Pule · University College London · OT2 · FY2022 · CA
Integrative analysis and modeling of human immune responses and pathologies
$2,095,068John Tsang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
LASER CELL PROCESSING FOR BASIC AND CLINICAL RESEARCH
$2,094,963Cyntellect, Inc. · R44 · FY2001 · RR
SPORE in Brain Cancer
$2,094,780Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
Genetics and Genomics of Leiomyosarcoma (LMS): Improved understanding of cancer biology and new approaches to diagnosis and treatment
$2,094,748Scott Michael Schuetze · University Of Michigan At Ann Arbor · P50 · FY2024 · CA
Improving the sensitivity and specificity of MRI-based biomarkers in Alzheimer's disease
$2,094,490Paul A. Yushkevich · University Of Pennsylvania · RF1 · FY2021 · AG